Diabetes poses considerable health and economic burdens in the United States, costing a staggering $412.9 billion, including $306.6 billion of direct medical costs and $106.3 billion of indirect expenses.1 Understanding the changing prevalence of diabetes and associated socioeconomic disparities is important for developing effective prevention and management strategies.2,3 This study aims to address knowledge gaps by examining recent trends in diabetes prevalence among US adults and its disparities based on socioeconomic status utilizing a nationally representative dataset from 2012 to 2022.
No takes yet. Share an insight, caveat, or question.
Neupane et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: